AT294830B - Verfahren zur Herstellung von 3-X-4-Chlor-1,2,5-thiadiazolen - Google Patents

Verfahren zur Herstellung von 3-X-4-Chlor-1,2,5-thiadiazolen

Info

Publication number
AT294830B
AT294830B AT1063570A AT1063570A AT294830B AT 294830 B AT294830 B AT 294830B AT 1063570 A AT1063570 A AT 1063570A AT 1063570 A AT1063570 A AT 1063570A AT 294830 B AT294830 B AT 294830B
Authority
AT
Austria
Prior art keywords
thiadiazoles
chloro
preparation
Prior art date
Application number
AT1063570A
Other languages
English (en)
Original Assignee
Frosst & Co Inc Charles E
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Frosst & Co Inc Charles E filed Critical Frosst & Co Inc Charles E
Application granted granted Critical
Publication of AT294830B publication Critical patent/AT294830B/de
Priority claimed from US00370994A external-priority patent/US3812182A/en
Priority claimed from US05/417,301 external-priority patent/US3962338A/en
Priority claimed from US425912A external-priority patent/US3892744A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/10—1,2,5-Thiadiazoles; Hydrogenated 1,2,5-thiadiazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/63—Esters of sulfonic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/04—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D263/06—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by oxygen atoms, attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT1063570A 1968-05-22 1969-05-21 Verfahren zur Herstellung von 3-X-4-Chlor-1,2,5-thiadiazolen AT294830B (de)

Applications Claiming Priority (13)

Application Number Priority Date Filing Date Title
US73133368A 1968-05-22 1968-05-22
US81809069A 1969-04-21 1969-04-21
US81808669A 1969-04-21 1969-04-21
US81847469A 1969-04-21 1969-04-21
US17223071A 1971-08-16 1971-08-16
US17223171A 1971-08-16 1971-08-16
US17223271A 1971-08-16 1971-08-16
US17914771A 1971-09-09 1971-09-09
US17914571A 1971-09-09 1971-09-09
US28401372A 1972-08-25 1972-08-25
US00370994A US3812182A (en) 1968-05-22 1973-06-18 S-bis-(2-lower alkyl amino hydroxy-methylethoxy)-methanes
US05/417,301 US3962338A (en) 1968-05-22 1973-11-19 Novel methods and compounds employed therein
US425912A US3892744A (en) 1968-05-22 1973-12-18 Process for preparing 4-{8 3-(substituted amino)-2-hydroxypropoxy{9 -1,2,5-thiadiazoles

Publications (1)

Publication Number Publication Date
AT294830B true AT294830B (de) 1971-12-10

Family

ID=27584550

Family Applications (3)

Application Number Title Priority Date Filing Date
AT483869A AT289788B (de) 1968-05-22 1969-05-21 Verfahren zur Herstellung eines optisch aktiven Thiadiazols und seiner Salze
AT1063470A AT305229B (de) 1968-05-22 1969-05-21 Verfahren zur Herstellung von S-1,2-Dihydroxy-3-aminopropan
AT1063570A AT294830B (de) 1968-05-22 1969-05-21 Verfahren zur Herstellung von 3-X-4-Chlor-1,2,5-thiadiazolen

Family Applications Before (2)

Application Number Title Priority Date Filing Date
AT483869A AT289788B (de) 1968-05-22 1969-05-21 Verfahren zur Herstellung eines optisch aktiven Thiadiazols und seiner Salze
AT1063470A AT305229B (de) 1968-05-22 1969-05-21 Verfahren zur Herstellung von S-1,2-Dihydroxy-3-aminopropan

Country Status (10)

Country Link
US (3) US3657237A (de)
AT (3) AT289788B (de)
BE (1) BE733387A (de)
CA (1) CA949069A (de)
CH (5) CH543478A (de)
DE (1) DE1925955A1 (de)
FR (2) FR2039306B1 (de)
GB (2) GB1267328A (de)
NL (1) NL153189B (de)
SE (2) SE388613B (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3892744A (en) * 1968-05-22 1975-07-01 Merck & Co Inc Process for preparing 4-{8 3-(substituted amino)-2-hydroxypropoxy{9 -1,2,5-thiadiazoles
JPS4913176A (de) * 1972-06-03 1974-02-05
US4011217A (en) * 1973-04-19 1977-03-08 Merck Sharp & Dohme (I.A.) Corporation 4-(3-amino-2-acyloxypropoxy)-1,2,5-thiadiazole compounds
US3891639A (en) * 1973-04-19 1975-06-24 Merck Sharp & Dohme 4-{8 3-Amino-2-acyloxypropoxy{9 -1,2,5-thiadiazole compounds
AU509371B2 (en) * 1975-08-07 1980-05-08 F. Hoffmann-La Roche Ag Diazepine Derivatives
US4097490A (en) * 1975-09-25 1978-06-27 Merck & Co., Inc. Pyroglutamic acid salts of t-butylamino-2,3-dihydroxypropane
US4119718A (en) * 1977-05-02 1978-10-10 Merck & Co., Inc. 3-Amino-2-oxy-propoxy-substituted isothiazoles
FI76795C (fi) * 1979-09-04 1988-12-12 Bristol Myers Co Foerfarande foer framstaellning av nya, terapeutiskt anvaendbara 3,4-disubstituerade 1,2,5-tiadiazol-1-oxider och -1,1-dioxider samt nya mellanprodukter.
ZA805250B (en) * 1979-09-04 1981-09-30 Bristol Myers Co Chemical compounds
NZ196227A (en) * 1980-02-19 1984-09-28 Merck & Co Inc 1,2,5-thiadiazole derivative and ophthalmic compositions
US4550117A (en) * 1982-07-26 1985-10-29 Merck & Co., Inc. 3-Cycloalkylamino-2-OR-propoxycyanopyridines, derivatives thereof, having anti-hypertensive activity
US4794111A (en) * 1984-05-23 1988-12-27 Bayer Aktiengesellschaft Dihydropyridine preparations containing β-blockers
US4644006A (en) * 1984-06-22 1987-02-17 Bristol-Myers Company Substituted 3,4-diamino-1,2,5-thiadiazoles having histamine H2 -receptor antagonist activity
FI82240C (fi) * 1988-10-20 1991-02-11 Huhtamaeki Oy Foerfarande foer framstaellning av farmakologiskt vaerdefullt s-timolol-hemihydrat.
US5320839A (en) * 1991-10-11 1994-06-14 Alcon Laboratories, Inc. Topical ophthalmic compositions comprising 4-(3-substituted amino-2-hydroxypropoxy)-1,2,5-thiadiazoles and methods for their use
US5523301A (en) * 1994-08-05 1996-06-04 Merck & Co., Inc. Optic nerve health
US5665745A (en) * 1994-10-24 1997-09-09 Eli Lilly And Company Heterocyclic compounds and their preparation and use
US6258350B1 (en) 1999-01-20 2001-07-10 Alcon Manufacturing, Ltd. Sustained release ophthalmic formulation
US7001615B1 (en) 2001-12-07 2006-02-21 Alcon, Inc. Sustained release ophthalmic, otic and nasal suspension
JP4613131B2 (ja) * 2003-02-05 2011-01-12 日立化成工業株式会社 摩擦材組成物及び摩擦材組成物を用いた摩擦材
US7090548B1 (en) * 2005-02-03 2006-08-15 International Business Machines Corporation Method of using a linear propulsor array for propulsion and navigation
WO2008112287A1 (en) 2007-03-12 2008-09-18 Nektar Therapeutics Oligomer-beta blocker conjugates
EP2050441A1 (de) * 2007-10-19 2009-04-22 Université Victor Segalen Bordeaux 2 Verwendung von Beta-Blockern für die Herstellung eines Medikaments zur Behandlung von Hämangiomen
US8987262B2 (en) 2007-10-19 2015-03-24 Universite de Bordeaux Use of a beta blocker for the manufacture of a medicament for the treatment of hemangiomas
US20110092507A1 (en) * 2009-10-20 2011-04-21 Chin-Tsai Fan Process for preparing R-(+)-3-morpholino-4-(3- tert-butylamino-2-hydroxypropoxy)-1,2,5-thiadiazole

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2964530A (en) * 1958-05-02 1960-12-13 Sterling Drug Inc 3-alkyl-4-hydroxymethyl-4-alkyloxazolidines

Also Published As

Publication number Publication date
US3657237A (en) 1972-04-18
AT289788B (de) 1971-05-10
SE421001B (sv) 1981-11-16
GB1264558A (de) 1972-02-23
FR2039306A1 (de) 1971-01-15
CH560710A5 (de) 1975-04-15
SE7410837L (de) 1974-08-27
FR2039306B1 (de) 1974-03-22
NL153189B (nl) 1977-05-16
BE733387A (de) 1969-11-21
DE1925955A1 (de) 1970-10-29
NL6907872A (de) 1969-11-25
AT305229B (de) 1973-02-12
US3781284A (en) 1973-12-25
CH544119A (de) 1973-12-28
CH554887A (de) 1974-10-15
FR2116583A1 (de) 1972-07-13
FR2116583B1 (de) 1982-03-19
CH553214A (de) 1974-08-30
SE388613B (sv) 1976-10-11
GB1267328A (en) 1972-03-15
US3766180A (en) 1973-10-16
CA949069A (en) 1974-06-11
CH543478A (de) 1973-12-14

Similar Documents

Publication Publication Date Title
AT294830B (de) Verfahren zur Herstellung von 3-X-4-Chlor-1,2,5-thiadiazolen
CH525183A (de) Verfahren zur Herstellung von 3,4-Dihydronaphthalino-noxy-2-hydroxypropylaminen
CH532611A (de) Verfahren zur Herstellung von 4 ,a-1 -Demethyl-7-halogen-7-desoxy-lincomycinen
AT289785B (de) Verfahren zur Herstellung von 1,5-disubstituierten 4-Cyanopyrazolen
CH526618A (de) Verfahren zur Herstellung von 1,3,2-Oxazaboriniden
CH547284A (de) Verfahren zur herstellung von 1-hydroxy-2-pyridonen.
CH529083A (de) Verfahren zur Herstellung von Tricyclo-(4,3,1,13,8)-undecan-4-on
CH558794A (de) Verfahren zur herstellung von 3-aroylpyrrolidinen.
CH508616A (de) Verfahren zur Herstellung von 2-Alkyl-3-hydroxy-4,5-dihydrofuran-4-onen
AT287665B (de) Verfahren zur Herstellung von 2,2-Dimethyl-3-hydroxypropanal
CH527185A (de) Verfahren zur Herstellung von 6,7-Dihydro-5H-pyrrolizinen
CH517110A (de) Verfahren zur Herstellung von 2,1,3-Benzothiadiazolen
CH497428A (de) Verfahren zur Herstellung von 1-Formyl-3-nitro-azacyclo-heptanon-(2)
CH525876A (de) Verfahren zur Herstellung von 3-Keto-6,7-methylen-20-spirox-4-enen
CH520143A (de) Verfahren zur Herstellung von 4,5,6,7-Tetrahydrobenzimidazolen
AT289052B (de) Verfahren zur Herstellung von 3-Ketobutanol-(1)
CH516564A (de) Verfahren zur Herstellung von 4,5,6-Tri-chlorpyrimidinen
CH516548A (de) Verfahren zur Herstellung von 2,3-Dihydro-2,2-dimethyl-7-acetamidobenzofuran
CH504438A (de) Verfahren zur Herstellung von 1,2,3,4,4a,5,6,10b-Octahydrobenz(h)isochinolin-6-on
CH523266A (de) Verfahren zur Herstellung von 1-Alkyl-5-phenyl-1,2,4,5-tetrahydro-3H-1,4-benzodiazepinen
AT281018B (de) Verfahren zur Herstellung von 3-Amino-4-brom-1,2,5-thiadiazol
CH514568A (de) Verfahren zur Herstellung von 6,7-Epoxy-citronellal
CH532572A (de) Verfahren zur Herstellung von 2,5-Diphenylpyrrolen
CH515253A (de) Verfahren zur Herstellung von 2,4-Diamino-6-alkylthio-s-triazinen
CH517088A (de) Verfahren zur Herstellung von 3B,14BB-Dihydroxy-carda-4,20(22)-dienoliden

Legal Events

Date Code Title Description
ELA Expired due to lapse of time